Dr. Peter Tapley
Peter is a highly experienced research scientist with expertise in management of facilities under Good Laboratory Practice quality standards. He has acted as study director on numerous GLP compliant toxicology studies and a wide range of pharmacology models. His achievements in the areas of toxicology and oncology are recognised by memberships of the US Society of Toxicology and the American Association for Cancer Research.
He has a comprehensive understanding of industry drug development and regulatory processes. This knowledge is based on 20+ years of experience in the biotechnology and pharmaceutical industry in the United States and Australia. His experience includes scientist and management positions at Ligand Pharmaceuticals (San Diego), GlaxoSmithKline (Philadelphia), GroPep Ltd (Adelaide) and RDDT Laboratories/vivoPharm (Melbourne).
Quality Assurance Manager
With a BSc (Hons) in Chemistry & MSc in Forensic Science, Simon Lake began his professional career with Glaxo Wellcome (now Glaxo SmithKline) where he worked as an Analytical Chemist in the UK. Having moved to Australia in 2006, Simon joined TetraQ as an Analyst & QA Representative for CIPDD/TetraQ ADME Bioanalytics before assuming the role of full-time Quality Assurance Manager for CIPDD/TetraQ in 2008.